The clinical manifestations of herpes infection depend on the pathogenic properties of the pathogen and on the state of immunity of the infected organism. Herpesviruses type 1-3 are predominantly neurotropic and cause diseases of the nervous system. The reproduction of the virus is carried out in the neurons of the nerve ganglia and epithelial cells, as they have a common ectodermal origin. Herpesviruses type 4, 5 and 8 are predominantly lymphotropic and cause diseases of the immune system. In a latent and persistent state, viruses are found in lymphocytes, monocytes, polymorphonuclear leukocytes, as they exhibit tropism for cells of mesenchymal origin. When the infection is reactivated, the virus is reproduced in cells of ectodermal origin, which leads to characteristic organ lesions. Type 6 and 7 viruses are both neurotropic and lymphotropic. They are capable to infect T-lymphocytes, B-lymphocytes, epithelial cells, endothelial cells, hepatocytes, fibroblasts, glial cells, stem cells, monocytes, macrophages, leukocytes, etc. They are able to promote the reactivation of other viruses, forming mixed forms, which leads to an aggravation of the clinical picture of the disease. Therapy of herpesvirus infections should be scientifically grounded, consistent, gradual, complex and include: specific antiviral treatment; immunotherapy; antibacterial therapy; detoxification therapy; symptomatic treatment and therapeutic measures aimed to eliminate various complications. Antiviral drugs for the treatment of herpes infection are divided into 4 groups: nucleoside analogs; drugs that cause the destruction of viruses located extracellularly; drugs that are active against intracellular viruses; drugs with a double effect. Modern therapy of herpesvirus infections is capable to suppress the reproductive activity of the reactivated virus, modulate the body's immune response, prevent and eliminate various complications of herpes infections, but is unable to affect the latent form of viruses. In the complex therapy of herpes infection, along with the specific treatment methods aimed to destroy the virus and to enhance the body's immunity, it is necessary to apply the entire range of therapeutic measures that help eliminate the accompanying symptoms and complications of diseases caused by herpesviruses

Keywords: herpesviruses, clinical manifestations, treatment

Full text: PDF (Ukr) 303K

1. Dyudyun AD, Polyon NN, Nagornyy AE. Gerpesvyrusnaya ynfektsyya. Klynyko-ymmunologycheskye osobennosty. Klynycheskaya lektsyya [Herpessruscular infection. Clinical and immunological features. Clinical lecture]. Dermatovenerologyya. Kosmetologyya. Seksopatologyya. 2015; 3(4): 119-142. [Russian]
2. Lebedeva TM, Egorova NYu, Koltunov YE, Karazhas NV, Rybalkyna TN, Kalugyna MYu, i dr. Virusy semeystva gerpesov i dlytelnyi subfebrilitet [Viruses of the herpes family and long-lasting subfebristitet]. Epidemyol infekts bolezny. Aktual vopr. 2014; 3: 20-24. [Russian]
3. Vykulov GKh. Gerpesvirusnye infektsyi cheloveka v novom tysyacheletii: klassifikatsiya, epidemiologiya i mediko-sotsialnoe znachenie [Herpesvirus infections of a person in the new millennium: classification, epidemiology and medical and social importance]. Epidemyol infekts bolezny. Aktual vopr. 2014; 3: 35-40. [Russian]
4. Patent 122479 Ukraine, МПК (2006): A61K 38/00, A61P 31/22 (2006.01), A61P 37/02 (2006.01). Sposib likuvannya khronichnogo retsydyvuyuchogo gerpesu I ta II typiv [Method of treating chronic recurrent herpes I and II types] / Suprunenko SM, Lyakhovskyy VI, Matokha OP, Lyakhovska NV, Kapustnyk YuO, Lyakhovskyy VI. (UA); zayavnik i vlasnik patentu VNZU "Ukrayinska medychna stomatologichna akademiya" (UA). № u201707566; zayavl 17.07.2017 ; opubl 10.01.2018. Byul № 1. [Ukrainian]
5. Kaspina AY, Isakov VA, Silin AV, Surdina ED, Gordeeva VA, Bukhartseva NA. Gerpesvirusnaya infektsiya. Osobennosti proyavlenyi v chelyustno-litsevoy oblasti [Herpessruscular infection. Features of manifestations in the maxillofacial region]. 2-e izd, ispr i dop. SPb: SpetsLit; 2018. 63 s. [Russian]
6. Kazmyrchuk VE, Maltsev DV. Rekomendatsii po lecheniyu gerpesvirusnykh infektsyi cheloveka [Recommendations for the treatment of herpesvirus person infections]. Ukr med Chasopys. 2012; 5(91): 94-106. [Russian]
7. Samaranayake L. Essential Microbiology for Dentistry. 5th ed. Elsevier; 2018 Mar 28. 391 p.
8. Isakov VA, Arkhipova EY, Isakov DV. Gerpecvirusnye infektsii cheloveka [Human herpesvirus infection]. 2-e izd, pererab i dop. SPb: SpetsLit; 2013. 670 s. [Russian]
9. Pokrovskyy VY, Pak SG, Bryko NY, Danylkyn BK. Infektsionnye bolezni epidemiologiya [Infectious diseases and epidemiology]. 3-e izd, ispr i dop. M: GEOTAR-medya; 2016. 1008 s. [Russian]
10. Kazmyrchuk VE, Maltsev DV. Klinika, diagnostika i lechenie gerpesvirusnykh infektsyi cheloveka [Clinic, diagnosis and treatment of human herpesvirus infections]. K: Feniks; 2009. 248 s. [Russian]
11. Lamont RD, Berne RA, Lantts MS, Leblank DD. Mikrobiologiya immunologiya dlya stomatologov [Microbiology and immunology for dentists]. M: Prakticheskaya medytsyna; 2010. 504 s. [Russian]
12. Synytsya PV. Genitalnyy gerpes: etiopatogenetychni, kliniko-epidemiologichni aspekty, kompleksna diagnostyka ta likuvannya, profilaktyka [Genital herpes: etiopathogenetic, clinical and epidemiological aspects, comprehensive diagnosis and treatment, prevention]. Dermatovenerologiya. Kosmetologiya. Seksopatologiya. 2011; 1(4): 115-129. [Ukrainian]
13. Oxford JS, Collier LH, Kellam P. Human virology. 5th ed. Oxford University Press; 2016. 349 p.
14. Okolysheva NV. Kliniko-virusologicheskaya kharakteristika gerpesvirusnykh infektsyi effektivnost immunomoduliruyushchey terapii u detey rannego vozrasta s ostroy respiratornoy virusnoy infektsiey [Clinical and virological characteristics of herpesvirus infections and the effectiveness of immunomodulatory therapy in young children with acute respiratory viral infection]. Abstr. PhDr. (Med.). M; 2017. 25 s. [Russian]